Zinnia Life Sciences
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Zinivog GM 1mg/500mg/0.3mg Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Zinivog GM 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Zinivog GM 1mg/500mg/0.3mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Zinivog GM 1mg/500mg/0.3mg Tablet.
Zinivog GM 1mg/500mg/0.3mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Zinivog GM 1mg/500mg/0.3mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Zinivog GM 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Zinivog GM 1mg/500mg/0.3mg Tablet is a combination of Glimepiride, Metformin and Voglibose, used to treat type 2 diabetes mellitus (DM). It works by improving blood glucose levels when taken along with proper diet and regular exercise. Glimepiride decreases blood glucose by increasing insulin release from the pancreas. Metformin reduces glucose production in the liver and enhances insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels.
Common side effects of Zinivog GM 1mg/500mg/0.3mg Tablet may include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Avoid this medicine if you are allergic to any of its components or excipients. It is also not advised for patients with moderate to severe kidney disease, inflammatory bowel disease (IBD), colonic ulcers and underlying metabolic acidosis including diabetic ketoacidosis.
No, Zinivog GM 1mg/500mg/0.3mg Tablet should not be taken with alcohol due to potential lowering of blood sugar levels (hypoglycemia) and increased risk of lactic acidosis.
Yes, Zinivog GM 1mg/500mg/0.3mg Tablet can cause hypoglycemia (low blood sugar level). It is essential to monitor your blood sugar levels regularly and be prepared with glucose tablets, honey or fruit juice in case of sudden low blood sugar. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky.
Store this medicine in its original container with a tightly closed lid. Follow any instructions mentioned on the label or packaging. Do not share it with others, pets, children, or anyone else without consulting your doctor.